Arnd Jonathan Obert1,2, Marcel Gutberlet1,2, Agilo Luitger Kern1,2, Till Frederik Kaireit1,2, Julian Glandorf1,2, Tawfik Moher Alsady1,2, Frank Wacker1,2, Jens M. Hohlfeld2,3,4, and Jens Vogel-Claussen1,2
1Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany, 2Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany, 3Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany, 4Department of Clinical Airway Research, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany
Synopsis
Diffusion
of fluorinated gas in the short-time regime was measured using multiple
gradient echo sequences with a single pair of trapezoidal gradient pulses.
Pulmonary alveolar surface-to-volume ratio (S/V) was calculated using a first-order
approximation of the time-dependent diffusion in a study with 20 healthy
volunteers and 22 patients with chronic obstructive pulmonary disease (COPD). Median
surface-to-volume ratio is significantly decreased in COPD patients compared to
healthy volunteers (P<.0001). No significant difference was found between
measurements within 7 days. Linear correlations were found with S/V from
hyperpolarized 129Xe MRI (r=0.85, P=.001) and the forced
expiratory volume in one second (r=0.68, P<.0001).
Introduction
Early
detection and adequate phenotyping are highly desirable for diagnosis and treatment of COPD1,2. Therefore, MRI of inhaled fluorinated gas provides a
cost-effective and non-invasive tool for direct ventilation measurement in the
human lung3. Examining the gas diffusion behavior allows for quantification
of pulmonary alveolar surface-to-volume ratio (S/V) which quantifies lung
microstructure for assessing e.g. emphysematous changes in COPD4,5.Methods
In
this study, 20 healthy volunteers and 22 patients with COPD (GOLD stage I – III) were
examined on a 1.5 T scanner. The study participants inhaled a mixture of 79% C3F8
and 21% O2 for nine breath-holds with a fixation of the inhaled gas
volume to 1/8 inspiratory vital capacity. During the first eight breath-holds
(duration 6 seconds each), ventilation imaging was performed using a 3D
gradient echo pulse sequence with golden-angle stack-of-stars k-space encoding.
During the ninth breath-hold, four images were acquired for S/V mapping in a
single breath-hold (duration 14 seconds). Three images were diffusion weighted
using additional 3D trapezoidal gradients with a fixed b-value (b = 12.59 s/cm2),
fixed gradient pulse length (δ = 1 ms), and varying diffusion times (Δ = 6 ms,
4 ms, 2 ms) and gradient strengths, respectively (|G| = [18.7, 23.3, 34.6] 10-5 T/cm). The first image was acquired without diffusion weighting as a
reference.
All
patients underwent spirometry and 19F MR imaging on the
same day and a second 19F MR scan after maximum 7 days for
repeatability measurement.
Hyperpolarized 129Xe
diffusion-weighted MR imaging was performed in 11 COPD patients prior to the
first 19F imaging session using a stack-of-spirals sequence as previously described
6. Detailed information on the imaging
parameters is provided in table 1.
19F
ventilation images were reconstructed using the parallel imaging and compressed
sensing algorithm of the BART toolbox7. In order to counter the low SNR, total variation and
directional total variation to the eighth ventilation image were regularized
when reconstructing the diffusion weighted images.8,9
To
obtain S/V maps, the diffusion weighted images (S) were divided by the
unweighted image (S0) followed by voxel-wise fitting to the first-order
approximation of the model function for apparent diffusion in a porous medium $$ \frac{S}{S_0}
= \exp{\left(-b\cdot D_{app}\right)} = \exp{\left( -b\cdot D_0 \left( 1 -
\frac{\alpha}{3}\frac{S}{V}\sqrt{D_0\Delta}\right)\right)}, $$ where α is a
prefactor compensating for the deviation from the narrow-pulse approximation10,11. Since the free diffusion D0 depends
on the ratio of C3F8 to O2 in the specific
voxel, its value was also determined within the fit procedure12.Results
Fluorinated
gas imaging procedures and maneuvers were well tolerated and no adverse events
were reported. Results are stated as medians over the whole lung with first and
third quartile, unless otherwise stated.
S/V
maps from exemplary patients can be found in figure 1, S/V values in different
stages of COPD are shown in figure
2.
The
median S/V was 164 cm-1 (160 cm-1 – 184 cm-1)
in healthy volunteers, 157 cm-1 (152 cm-1 – 164 cm-1)
in COPD patients with GOLD stage I, 132 cm-1 (105 cm-1 – 151 cm-1)
in COPD patients with GOLD stage II, and 81 cm-1 (64 cm-1 – 116 cm-1)
in COPD patients with GOLD stage III. Taken together, patients with COPD had a median S/V
of 126 cm-1 (87 cm-1 – 144 cm-1).
Significant
differences could be found between healthy volunteers and patients with GOLD II
(P = .007), between patients with GOLD I and GOLD III (P = .025), and between
healthy volunteers and patients with GOLD III (P < .0001). A significant difference in S/V was measured
between healthy volunteers and COPD patients (P < .0001).
Bland-Altman
plots comparing measurements on the first and the second scan day are shown in
figure 3. No significant differences for S/V values between first and second
scan could be found in any of the patient groups. The Bland-Altman plots show a
mean bias of 0.8 cm-1 and the 95% limits of agreement of ± 45 cm-1
for healthy volunteers as well as a mean bias of 9 cm-1 and 95%
limits of agreement of ± 37 cm-1 for COPD patients. The median
coefficient of variation between first and second measurement for healthy
volunteers was 4.3% and for COPD patients 6.7%.
For
11 COPD patients, a strong linear correlation between median S/V values
measured with 19F and 129Xe could be found (r = 0.85, P =
.001). Bland-Altman plot analysis shows a non-significant bias of -11 cm-1
(P = .145) and the 95% limits of agreement of ± 47 cm-1.
Correlation and Bland-Altman plots are shown in figure 4.
A
moderate linear correlation between 19F S/V values and the predicted
forced expiratory volume in one second (FEV1) could be found in all
examined subjects (r = 0.68, P < .0001). A correlation plot is shown in
figure 5.Discussion and Conclusion
Although
the sequence design was rather simple, this study shows the general feasibility
and the good repeatability of in vivo S/V mapping with 19F diffusion
MRI. The provided
values seem to be reasonable using the proposed theoretical model and sequence
design when compared
to measurements from 129Xe and spirometry as well as
literature values for histological studies and CT imaging13–15.Acknowledgements
This
work was supported by the German Center for Lung Research (DZL) and the Fritz
Behrens Foundation. The authors thank Frank Schröder, Melanie Pfeifer, and
Cheng-Kai Huang for experimental support, as well as E. Tobias Krause for
in-depth advice on statistical evaluation.References
1.
Laucho-Contreras ME, Cohen-Todd M. Early diagnosis of COPD: myth or a true
perspective. European Respiratory Review. 2020;29(158):200131.
doi:10.1183/16000617.0131-2020
2. Lange P, Halpin DM, O’Donnell DE, MacNee W. Diagnosis,
assessment, and phenotyping of COPD: beyond FEV₁. International journal of
chronic obstructive pulmonary disease. 2016;11 Spec Is(Spec Iss):3–12.
doi:10.2147/COPD.S85976
3. Couch MJ, Ball IK, Li T, Fox MS, Littlefield SL, Biman B,
Albert MS. Pulmonary Ultrashort Echo Time 19F MR Imaging with Inhaled
Fluorinated Gas Mixtures in Healthy Volunteers: Feasibility. Radiology.
2013;269(3):903–909. doi:10.1148/radiol.13130609
4. Itoh H, Nishino M, Hatabu H. Architecture of the Lung:
Morphology and Function. Journal of Thoracic Imaging. 2004;19(4).
5. Thurlbeck WM. Internal surface area and other measurements
in emphysema. Thorax. 1967;22(6):483–496. doi:10.1136/thx.22.6.483
6. Kern AL, Gutberlet M, Moher Alsady T, Welte T, Wacker F,
Hohlfeld JM, Vogel-Claussen J. Investigating short-time diffusion of
hyperpolarized 129Xe in lung air spaces and tissue: A feasibility study in
chronic obstructive pulmonary disease patients. Magnetic Resonance in Medicine.
2020;84(4):2133–2146. doi:https://doi.org/10.1002/mrm.28264
7. Uecker M, Ong F, Tamir JI, Bahri D, Virtue P, Cheng JY,
Lustig M. Berkeley advanced reconstruction toolbox. Proc. Intl. Soc. Mag.
Reson. Med. 2015;23:2486. doi:10.1002/mrm.25176
8. Obert AJ, Gutberlet M, Kern AL, Kaireit TF, Grimm R,
Wacker F, Vogel-Claussen J. 1H-guided reconstruction of 19F gas MRI in COPD
patients. Magnetic Resonance in Medicine. 2020. doi:10.1002/mrm.28209
9. Ehrhardt MJ, Betcke MM. Multicontrast MRI Reconstruction
with Structure-Guided Total Variation. SIAM Journal on Imaging Sciences.
2016;9(3):1084–1106. doi:10.1137/15M1047325
10. Mitra PP, Sen PN, Schwartz LM. Short-time behavior of the
diffusion coefficient as a geometrical probe of porous media. Physical Review
B. 1993;47(14):8565–8574. doi:10.1103/PhysRevB.47.8565
11. Miller GW, Carl M, Mata JF, Cates GD, Mugler JP.
Simulations of Short-Time Diffusivity in Lung Airspaces and Implications for
S/V Measurements Using Hyperpolarized-Gas MRI. IEEE Transactions on Medical
Imaging. 2007;26(11):1456–1463. doi:10.1109/TMI.2007.903192
12. Chang Y V., Conradi MS. Relaxation and diffusion of
perfluorocarbon gas mixtures with oxygen for lung MRI. Journal of Magnetic
Resonance. 2006;181(2):191–198. doi:10.1016/j.jmr.2006.04.003
13. Coxson HO, Rogers RM, Whittall KP, D’Yachkova Y, Paré PD,
Sciurba FC, Hogg JC. A Quantification of the Lung Surface Area in Emphysema
Using Computed Tomography. American Journal of Respiratory and Critical Care
Medicine. 1999;159(3):851–856. doi:10.1164/ajrccm.159.3.9805067
14. Yablonskiy DA, Sukstanskii AL, Woods JC, Gierada DS,
Quirk JD, Hogg JC, Cooper JD, Conradi MS. Quantification of lung microstructure
with hyperpolarized 3He diffusion MRI. Journal of Applied Physiology.
2009;107(4):1258–1265. doi:10.1152/japplphysiol.00386.2009
15. West JB. Respiratory physiology: the essentials.
Lippincott Williams & Wilkins; 2012.